These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7188493)

  • 1. [Update on antibiotic therapy. 2) Rifampicin].
    Di Nola F
    Minerva Med; 1982 Feb; 73(7):357-62. PubMed ID: 7188493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Update on antibiotic therapy. 27) Ceftazidime].
    di Nola F
    Minerva Med; 1984 Oct; 75(38):2253-61. PubMed ID: 6390255
    [No Abstract]   [Full Text] [Related]  

  • 3. [Update on antibiotic therapy. 30) Cefonicid].
    di Nola F
    Minerva Med; 1985 Apr; 76(16):819-25. PubMed ID: 4000526
    [No Abstract]   [Full Text] [Related]  

  • 4. [Update on antibiotic therapy. 10) Cefaclor].
    Di Nola F
    Minerva Med; 1982 Oct; 73(38):2629-32. PubMed ID: 6821380
    [No Abstract]   [Full Text] [Related]  

  • 5. [Update on antibiotic therapy. 6) Amikacin].
    Di Nola F
    Minerva Med; 1982 Jun; 73(24):1749-54. PubMed ID: 7188492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Rifampicin in present-day chemotherapy of bacterial infections].
    Navashin SM; Navashin PS
    Antibiot Khimioter; 1992 Jun; 37(6):41-8. PubMed ID: 1417344
    [No Abstract]   [Full Text] [Related]  

  • 7. [Update on antibiotic therapy. 19) Cefotetan].
    Di Nola F
    Minerva Med; 1983 Nov; 74(43):2653-8. PubMed ID: 6379515
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro comparison of ciprofloxacin to parenteral antibiotics.
    Speciale A; Caccamo F; Nicoletti G
    J Chemother; 1989 Jul; 1(4 Suppl):154-6. PubMed ID: 16312349
    [No Abstract]   [Full Text] [Related]  

  • 9. [Update on antibiotic therapy. 18) Lincomycin].
    Di Nola F
    Minerva Med; 1983 Jun; 74(25):1511-6. PubMed ID: 6431333
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis].
    Di Nola F; Eandi M; Soranzo ML; Capra E; Bosio G; Bramato C; Salassa B; Bendiscioli L
    Minerva Med; 1981 Apr; 72(14):875-92. PubMed ID: 7219797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of parenterally administered rifampicin into bone tissue.
    Roth B
    Chemotherapy; 1984; 30(6):358-65. PubMed ID: 6518835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update on antibiotic therapy. 3) Josamycin].
    Di Nola F
    Minerva Med; 1982 Mar; 73(11):621-4. PubMed ID: 7188491
    [No Abstract]   [Full Text] [Related]  

  • 13. Rational choice of an oral beta-lactam antibiotic.
    Periti P
    J Chemother; 1997 Sep; 9 Suppl 4():1-23. PubMed ID: 9373786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetics of rifampicin].
    Kohno H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Jan; 25(1):32-7. PubMed ID: 3599578
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute post-surgical infection of joint arthroplasty.
    Soriano A; García S; Bori G; Almela M; Gallart X; Macule F; Sierra J; Martínez JA; Suso S; Mensa J
    Clin Microbiol Infect; 2006 Sep; 12(9):930-3. PubMed ID: 16882303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of intravenous rifampicin.
    Nitti V; Virgilio R; Patricolo MR; Iuliano A
    Chemotherapy; 1977; 23(1):1-6. PubMed ID: 832508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic studies on rifampicin. III. Effect of phenobarbital on the half-life of the antibiotic.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Nicolis FB
    Tijdschr Gastroenterol; 1974; 17(3):151-8. PubMed ID: 4454053
    [No Abstract]   [Full Text] [Related]  

  • 18. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA; Rossolini GM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antimicrobial modified silicone peritoneal catheter with activity against both Gram-positive and Gram-negative bacteria.
    Bayston R; Fisher LE; Weber K
    Biomaterials; 2009 Jun; 30(18):3167-73. PubMed ID: 19289248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.